Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Immunyx Pharma
Immunyx Pharma Overview
Immunyx Pharma is a drug development company focused on modulating neutrophil function to treat disease. Using the company's platform technology to specifically manipulate neutrophils using a targeted nanoparticle, Immunyx will bring new therapies to several diseases where neutrophil treatment could advance a cure.
Immunyx Pharma's neutrophil-targeting technology is based on years of basic and translational research by professors Zvika Granot and Zvi Fridlender at the Hebrew University.